ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis

Atherosclerosis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles